BnR Summit 2025

Belt and Road Summit 2025- Deal-making

10 – 16 Sept 2025 | China (Hong Kong)

ProjectUpdated on 3 September 2025

Estelle Biovita

Daisy Tan

Business Development Manager at InnoHK Centre for Translational Stem Cell Biology

Hong Kong, China (Hong Kong)

About

Estelle Biovita LTD is a biotechnology company specializing in science-driven skincare and cosmeceutical innovation through its proprietary ingredient, STEM ELIXIR. This breakthrough formulation harnesses the regenerative power of human stem cell secretions to enhance skin repair and renewal. Specially designed for sensitive skin, STEM ELIXIR delivers research-backed benefits including anti-ageing effects, skin barrier restoration, and inflammation relief.

Project Location

  • China (Hong Kong)

Project Format

  • Public-Private Partnership Project

ESG (Environmental, Social, and Governance)

  • No

Project Stage

  • Project Planning

Main Project Sector

  • Technology

Technology

  • Bio-Tech
  • Health Technology

Total Project Value

  • 500,000 USD or Below

Investment Capital Required

  • 1,000,001 to 2,500,000 USD

Interested Format of Cooperation

  • Joint Venture
  • Open for Negotiation
  • R&D Cooperation

Preferred Financing Model

  • Open for negotiation

Previous Funding Stage

  • None

Main Service(s) Required

  • Financial Services
  • Professional Services

Organisation

InnoHK Centre for Translational Stem Cell Biology

Hong Kong Science and Technology Park, China (Hong Kong)

Similar opportunities